Dr Vibeke Catts is the Study Coordinator of the Older Australian Twins Study, which aims to determine the genetic and environmental influences on the ageing process, and the extent to which these determinants interact.

Prior to joining CHeBA, Dr Catts held a Post-Doctoral appointment at Neuroscience Research Australia, where she researched molecular and cellular pathology in blood and brain from individuals with schizophrenia. Dr Catts also investigates antipsychotic drugs as potential treatments for glioblastoma in collaboration with A/Professor Lutze-Mann, School of Biotechnology and Biomolecular Sciences, UNSW Sydney.